Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
28M
Market Cap:
$1.19B
Avg Volume:
489541
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Analysts' Rating And Target Changes: AEGR, CHMT, DPZ, KAR, MRVL
Dec 27, 2012 12:34 PM |
DPZ
,
KAR
,
MRVL
Analysts' Price Target Changes: AEGR, INFI, JDSU
Dec 26, 2012 12:48 PM |
INFI
,
JDSU
Stocks End Lower On Continued 'Cliff' Uncertainty; Yahoo! (YHOO) Rises
Dec 24, 2012 02:23 PM |
ALXA
,
HLF
,
OIIM
,
RF
,
YHOO
,
YUM
More Articles on AEGR..
Press Releases
Free Research Reports on AEGR, DHI, SOL and WMT Issued by the Paragon Report
May 17, 2013 08:20 AM |
DHI
,
SOL
,
WMT
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
May 03, 2013 04:05 PM |
Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 03, 2013 08:00 AM |
More Press Releases on AEGR..
SEC Filings
Form 4 Aegerion Pharmaceuticals For: Mar 04 Filed by: EDELMAN JOSEPH (10K)
Mar 06, 2013 05:17 PM
Form 4 Aegerion Pharmaceuticals For: Feb 01 Filed by: EDELMAN JOSEPH (10K)
Feb 05, 2013 04:11 PM
Form 4 Aegerion Pharmaceuticals For: Jan 18 Filed by: EDELMAN JOSEPH (10K)
Jan 22, 2013 01:32 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
AEGR
Compare to S&P
YTD
63.08 %
49.55 %
4 Weeks
8.10 %
8.21 %
12 Weeks
45.53 %
40.64 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-45.76 %
EPS Growth in Last Year:
-40.98 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##